These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7812091)

  • 41. Cost analysis of glaucoma medications.
    Fiscella RG; Jensen MK
    Am J Ophthalmol; 2008 Jun; 145(6):1108-9; author reply 1109. PubMed ID: 18503789
    [No Abstract]   [Full Text] [Related]  

  • 42. Allergic contact dermatitis due to beta-blockers in eye drops: a retrospective analysis of multicentre surveillance data 1993-2004.
    Jappe U; Uter W; Menezes de Pádua CA; Herbst RA; Schnuch A
    Acta Derm Venereol; 2006; 86(6):509-14. PubMed ID: 17106597
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detrimental effect of preservatives in eyedrops: implications for the treatment of glaucoma.
    Baudouin C
    Acta Ophthalmol; 2008 Nov; 86(7):716-26. PubMed ID: 18537937
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prepared association of metipranolol 0.1% + pilocarpine 2% and of timolol 0.5% + pilocarpine 2%. Comparison of clinical efficacy and topical tolerability in the treatment of patients affected by POAG tonometrically uncontrolled with beta-blocker alone (two-centre study).
    Boles Carenini B; Brogliatti B; Dorigo MT; Vadalà G; Protti R; Bellone A
    Acta Ophthalmol Scand Suppl; 1997; (224):54-5. PubMed ID: 9589740
    [No Abstract]   [Full Text] [Related]  

  • 45. Using multidose eyedrops in a health care setting: a policy and procedural approach to safe and effective treatment of patients.
    Jensen MK; Nahoopii R; Johnson B
    JAMA Ophthalmol; 2014 Dec; 132(12):1476-9. PubMed ID: 25188508
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The COMOD system. A preservative-free multidose container for eyedrops].
    Teping C; Wiedemann B
    Klin Monbl Augenheilkd; 1994 Oct; 205(4):210-7. PubMed ID: 7823521
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cost of beta-adrenergic receptor blocking agents for ocular hypertension.
    Ball SF; Schneider E
    Arch Ophthalmol; 1992 May; 110(5):654-7. PubMed ID: 1349806
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cost of beta-blocker therapy.
    Zimmerman TJ
    Arch Ophthalmol; 1997 Jul; 115(7):914. PubMed ID: 9230834
    [No Abstract]   [Full Text] [Related]  

  • 49. Glaucoma medical treatment--2002: does yearly cost now equal the year?
    Doyle JW; Smith MF; Tierney JW
    Optom Vis Sci; 2002 Aug; 79(8):489-92. PubMed ID: 12199540
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of preservatives and antiglaucomatous medication on the histopathology of the conjunctiva.
    Mietz H; Niesen U; Krieglstein GK
    Graefes Arch Clin Exp Ophthalmol; 1994 Sep; 232(9):561-5. PubMed ID: 7959096
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of application systems for autologous serum eye drops.
    Spaniol K; Koerschgen L; Sander O; Koegler G; Geerling G
    Curr Eye Res; 2014 Jun; 39(6):571-9. PubMed ID: 24400979
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Extempore prepared ophthalmic solutions and ophthalmic ointments].
    Berggren L; Renström A
    Lakartidningen; 1978 Jan; 75(3):137-40. PubMed ID: 625158
    [No Abstract]   [Full Text] [Related]  

  • 53. [A correct understanding of preservatives in eye drops].
    Liu Z; Huang C
    Zhonghua Yan Ke Za Zhi; 2015 Sep; 51(9):641-4. PubMed ID: 26693647
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A clinical pathologic study of mercurialentis medicamentosus.
    Garron LK; Wood IS; Spencer WH; Hayes TL
    Trans Am Ophthalmol Soc; 1976; 74():295-320. PubMed ID: 867632
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Compatibility of a commercially available low-density polyethylene eye-drop container with antimicrobial preservatives and potassium ascorbate.
    Barnes AR
    J Clin Pharm Ther; 1995 Dec; 20(6):341-4. PubMed ID: 8847373
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Further experience with adrenaline eye drops in glaucouma therapy].
    Fechner PU
    Klin Monbl Augenheilkd; 1969 Jan; 154(1):19-31. PubMed ID: 5356000
    [No Abstract]   [Full Text] [Related]  

  • 57. Temperature-mediated absorption of phenylmercuric nitrate on polyethylene and polypropylene containers in chloramphenicol eye drops.
    Charoo N; Chiew M; Tay A; Lian L
    Cutan Ocul Toxicol; 2014 Sep; 33(3):242-6. PubMed ID: 24147942
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Advantages of Ocusert treatment (author's transl)].
    Wagner E
    Klin Monbl Augenheilkd; 1978 Sep; 173(3):370-4. PubMed ID: 750711
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assessment of risk of microbial contamination by use of multidose containers of injectable products.
    Christensen EA; Mordhorst CH; Jepsen OB
    J Hosp Infect; 1992 Apr; 20(4):301-4. PubMed ID: 1350606
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Drop size of commercial glaucoma medications.
    Lederer CM; Harold RE
    Am J Ophthalmol; 1986 Jun; 101(6):691-4. PubMed ID: 3717253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.